Invention Grant
- Patent Title: Truncated L1 protein of human papillomavirus type 33
- Patent Title (中): 人类乳头瘤病毒33型的截短L1蛋白
-
Application No.: US14122150Application Date: 2012-05-22
-
Publication No.: US09249193B2Publication Date: 2016-02-02
- Inventor: Shaowei Li , Xianglin Kong , Minxi Wei , Huirong Pan , Jun Zhang , Ningshao Xia
- Applicant: Shaowei Li , Xianglin Kong , Minxi Wei , Huirong Pan , Jun Zhang , Ningshao Xia
- Applicant Address: CN Fujian CN Fujian
- Assignee: Xiamen University,Xiamen Innovax Biotech Co. Ltd.
- Current Assignee: Xiamen University,Xiamen Innovax Biotech Co. Ltd.
- Current Assignee Address: CN Fujian CN Fujian
- Agency: Banner & Witcoff, Ltd.
- Priority: CN201110136560 20110525
- International Application: PCT/CN2012/075865 WO 20120522
- International Announcement: WO2012/159562 WO 20121129
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/005 ; A61K39/00
Abstract:
The present invention relates to a truncated L1 protein of Human Papillomavirus (HPV) Type 33, a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein and the virus-like particle are useful for preventing HPV (particularly HPV33) infection, and a disease caused by HPV (particularly HPV33) infection, such as cervical cancer. The invention also relates to the use of the protein and the virus-like particle in the preparation of a pharmaceutical composition or a vaccine for preventing HPV (particularly HPV33) infection, and a disease caused by HPV (particularly HPV33) infection, such as cervical cancer.
Public/Granted literature
- US20140147460A1 TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 33 Public/Granted day:2014-05-29
Information query
